Himadri Speciality Chemical Q1FY27 Revenue Up 28% YoY to ₹1,432 Crore
Himadri Speciality Chemical reported Q1FY27 consolidated revenue of ₹1,432 crore, up 28% YoY. EBITDA increased 33% to ₹313 crore, and PAT rose 27% to ₹228 crore. The company launched India's first CNT plant and is investing in Super Speciality Carbon Black and LFP Cathode Active Material production.
The significant year-on-year financial growth and strategic investments in new energy materials and advanced chemicals are likely to have a material positive impact on the company's future prospects and investor sentiment.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT, indicating positive financial performance. Additionally, strategic investments in new technologies like CNT and LFP cathode materials signal future growth potential.
Himadri Speciality Chemical Limited has announced its financial results for the quarter ended June 30, 2026. The company reported a consolidated revenue from operations of ₹1,431.88 crore, marking a significant year-on-year increase of 28.04% from ₹1,118.29 crore in Q1FY26. EBITDA also saw a substantial rise of 33.10% to ₹313.11 crore, compared to ₹235.25 crore in the same period last year. Profit After Tax (PAT) grew by 27.36% to ₹228.43 crore from ₹179.36 crore year-on-year.
The company highlighted key operational achievements including the launch of India's first Carbon Nano Tube (CNT) plant with a Capex of ₹70 crore and a target capacity of 200 MTPA by Q4FY27. Furthermore, Himadri is investing ₹170 crore to expand its Super Speciality Carbon Black (SSCB) production by 6,000 MTPA from its existing capacity. The company is also progressing with its new energy material initiatives, with Phase 1 of its LFP Cathode Active Material plant expected to be operational in Q3FY27 and Phase 1 of Anthraquinone & Carbazole production set for Q2FY27.
Himadri's strategic roadmap includes significant investments in high-growth businesses and a transition towards advanced materials. The company aims to compress three decades of growth into the next few years, driven by innovation, sustainability, and value addition across its product portfolio, including speciality chemicals and battery materials.
What to do with a filing like this
Himadri Speciality Chemical Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Himadri Speciality Chemical Limited. Read the original for the full detail.